Skip to content
Clinical Trials – home
Dbv Technologies
Sponsor

Dbv Technologies

France 107 Avenue De La Republique, 92320, France

About the sponsor

Dbv Technologies focuses on peanut allergy, with clinical research centered on improving desensitization and long-term management in children affected by this IgE-mediated allergy.

  • Peanut allergy
  • Food allergen immunotherapy
  • Allergic disease in children

The sponsor’s research activity includes studies in young pediatric populations, reflecting a strong interest in early-life allergy care and the clinical handling of persistent food hypersensitivity.

About Specializations

Dbv Technologies runs clinical trials in conditions such as Food allergy, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Food allergy

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Water For Injection
  • Sponsor:Dbv Technologies

Food allergy

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Arachis Hypogaea Extract
  • Sponsor:Dbv Technologies
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Water For Injection
  • Sponsor:Dbv Technologies

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).